---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-025888"
form_type: "8-K"
ticker: "QSI"
cik: "0001816431"
company_name: "Quantum-Si Inc"
filed_at: "2023-05-22T23:59:59+00:00"
generated_at: "2026-06-14T18:26:31.183161+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Quantum-Si appoints Jack Kenny to Board of Directors, effective May 19, 2023

## Summary
- Jack Kenny, CEO of Meridian Bioscience, appointed to Quantum-Si board effective May 19, 2023.
- He will serve on the Nominating and Corporate Governance and Compensation Committees.
- Mr. Kenny brings over 30 years of operational and commercial leadership in healthcare and diagnostics.
- He is considered independent under Nasdaq rules and will receive standard nonemployee director compensation.

## SEC filing metadata
- accession: 0001140361-23-025888
- form_type: 8-K
- ticker: QSI
- cik: 0001816431
- company_name: Quantum-Si Inc
- filed_at: 2023-05-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816431/000114036123025888/0001140361-23-025888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816431/000114036123025888/brhc20053170_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-025888
- JSON: https://secwatch.observer/filing/0001140361-23-025888.json
- Plain text: https://secwatch.observer/filing/0001140361-23-025888.txt

## Key facts
- Executive change
  Jack Kenny was appointed as Director at Quantum-Si Inc.
  - Action: appointed
  - Role: Director
  source text: appointed John Patrick (“Jack”) Kenny to the Board, effective as of May 19, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816431/000114036123025888/0001140361-23-025888-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.